Hi-Tech Pharmacal Short on Sterility, FDA Says

Drug Industry Daily
A A
A New York drugmaker failed to follow proper procedures for sterile handling of products, the FDA said.

To View This Article:

Login

Subscribe To Drug Industry Daily